Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tianchen Biotechnology

Request full access

Design, development, and sales of ophthalmology-related medical products

Heping District, ChinaFounded 2018Biotech & Life Sciences

About Tianchen Biotechnology

Based in Tianjin, China, Tianchen (Tianjin) Biotechnology Co., Ltd. is a privately held company established in 2018 that specializes in the research, development, production, and sale of ophthalmic medical devices. The firm directs its efforts toward creating high-tech solutions for unmet clinical needs within the eye care sector, manufacturing both active medical devices and passive consumable products. Its client base includes both individual patients, for whom it provides portable treatment and care equipment, and medical institutions, which are offered comprehensive diagnostic and therapeutic solutions.

The company's product lines are segmented into categories for glaucoma and dry eye treatment. A notable achievement for the company was securing the Class III Medical Device Registration Certificate for its Ophthalmic Intense Pulsed Light (IPL) Therapeutic Device in late 2024. This was followed by the pioneering implantation of its Minimally Invasive Glaucoma Drainage System at Beijing Tongren Hospital. The business model appears to focus on the direct sale of these specialized medical devices and consumables to healthcare providers and patients.

Financially, Tianchen Biotechnology is venture-backed and has completed multiple rounds of funding. In March 2024, the company raised $13.9 million in a Series A1 round, with CMB International Capital participating as an investor. The company's team includes talent from prominent institutions such as Tsinghua University, Beihang University, and Tianjin University, bringing together expertise in materials science, optics, and clinical ophthalmology.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
19.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Jun 2025 $28M $110M Honghui Capital ↗
SERIES A✓Equity / VC Mar 2024 $14M $55M CMB International ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Tianchen Biotechnology in the Heping District ecosystem

Live from Dealroom

The Tianchen Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • CMB International

Series B and later1 investor entered at this stage

  • Honghui Capital
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Heping District HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tianchen Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tianchen Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.